跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS
Approved
STANDARD
FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS
Merck Sharp & Dohme B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 18, 2021
Approval ID
0fced9798083f04e
Company
Merck Sharp & Dohme B.V.
Type
Standard
Approval Details
Approval Id
0fced9798083f04e
Drug Cima Aemps Name
FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS
Register Number
05310007IP1
Holder Company Name
Merck Sharp & Dohme B.V.
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/merck-sharp-and-dohme-bv
Authorization Date
2021-05-18
Dosage Form
COMPRIMIDO
Dose
70 mg/5600 UI
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Merck Sharp & Dohme B.V.
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Company Information
Pharmaceutical Company Name
Merck Sharp & Dohme BV
Country Name
Netherlands
Active Ingredients
ALENDRONATO SODIO TRIHIDRATO
70 mg
COLECALCIFEROL
5600 UI
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 18, 2021
Approval ID
0fced9798083f04e
Type
Standard
Back to CIMA-AEMPS Approvals